| 1 | 08:00-08:10 |
Opening Remarks |
|
||||||||
| 1 | 08:20-08:30 |
Genetics in prostate cancer: from hereditary risk to precision medicine |
|
|||||
| 2 | 08:30-08:40 |
All Roads Lead to AR: The Androgen Receptor in Modern Prostate Cancer Care |
|
|||||
| 3 | 08:40-08:50 |
Immunosuppressive and Prognostic Significance of MS4A4A-Positive Macrophages in Bladder Cancer |
|
|||||
| 4 | 08:50-09:00 |
Single-Cell and Spatial Transcriptomics Reveal Metastatic Subtyping and Molecular Mechanisms of Pheochromocytoma |
|
|||||
| 5 | 09:00-09:10 |
The VGF-MYH9-GSK3β-Wnt/β-Catenin Axis Promotes Prostate Cancer Progression by Reprogramming Glycolysis and the Immune Microenvironment |
|
|||||
| 6 | 09:10-09:20 |
A clinically translatable super-inert near-infrared fluorescent dye for surgical navigation |
|
|||||
| 7 | 09:20-09:30 |
Advancing Clinical Research in Diabetic Kidney Disease: Experience from the DYNAMO Study |
|
|||||
| 8 | 09:30-09:40 |
Clinical Big Data and Artificial Intelligence-Based Integrated Diagnosis and Treatment for Prostate Cancer |
|
|||||
| 1 | 09:40-09:50 |
AR-degrading peptide, a novel solution for prostate cancer |
|
|||||
| 2 | 09:50-10:00 |
SIRT5-Mediated Desuccinylation of FASN Regulates Lipid Metabolic Reprogramming and Promotes Prostate Cancer Cell Proliferation |
|
|||||
| 3 | 10:00-10:10 |
The DIS3–glycoRNA Axis Drives Early Tumor Immune Evasion by Remodeling DC–T Cell Immune Responses |
|
|||||
| 4 | 10:10-10:20 |
VHL inhibits autophagy and tumor development by modulating ATG14 hydroxylation in a PHD1-dependent manner |
|
|||||
| 5 | 10:20-10:30 |
SLC26A7+ Cancer-Associated Fibroblasts Promote Axitinib Resistance in Renal Cell Carcinoma via TET1 Lactylation Modification |
|
|||||
| 6 | 10:30-10:40 |
Cytoskeletal Protein KRT14 Governs Cisplatin Resistance by Modulating eIF4H-Dependent ACOX2 Translation and Lipid Metabolism in Bladder Cancer |
|
|||||
| 7 | 10:40-10:50 |
A Novel Natural Tumor-Suppressive Micropeptide Removes the TRIM25-Mediated Anti-Ferroptosis Barrier and Inhibits Bladder Cancer Progression |
|
|||||
| 8 | 10:50-11:00 |
Environmental Pollutant DEHP Drives Castration-Resistant Prostate Cancer Progression via OTUB2-Mediated Deubiquitination of MDM2 |
|
|||||
| 1 | 11:00-11:10 |
|
|
|||||
| 2 | 11:10-11:20 |
TE-RPA: A Single-Tube Telomerase Extension-Recombinase Polymerase Amplification-Based Electrochemical Biosensor for Precise Diagnosis of Urothelial Carcinoma |
|
|||||
| 3 | 11:20-11:30 |
Integrative spatial dissection of tumor microenvironment architecture in bladder cancer invasion |
|
|||||
| 4 | 11:30-11:40 |
Epigenomic Analysis Reveals AR-Associated Enhancer RNAs Modulate LTF Transcription to Influence Ferroptosis in Prostate Cancer |
|
|||||
| 5 | 11:50-12:00 |
Exosomal ST6GAL1 from Prostate Cancer Promotes Perineural Invasion by Regulating Neuronal NGF Secretion via the Integrin β1/FAK/ERK Signaling Axis |
|
|||||
| 6 | 11:50-12:00 |
LncCAM6A Promotes Sunitinib Resistance in Renal Cell Carcinoma by Activating Pyrimidine Synthesis via RBM15-Mediated m6A Modification of NAGS |
|
|||||
| 7 | 12:00-12:10 |
Single-Cell Glyco-LacNAc Multi-Omics-Based Development of a Draining Lymph Node-Derived T Cell Therapy for Bladder Cancer |
|
|||||
| 8 | 12:10-12:20 |
The Non-Canonical Function of Claudin-1 Drives Prostate Cancer Lineage Plasticity and Chemotherapy Resistance by Alleviating Lethal Endoplasmic Reticulum Stress |
|
|||||
| 1 | 13:30-13:40 |
Opening Remarks |
|
|||||
| 1 | 13:40-13:50 |
Fasting-Mimicking Diet-Driven Taurocholic Acid Reduction Enhances Renal Cell Carcinoma Immunotherapy by Attenuating MDSC-Mediated Immunosuppression |
|
|||||
| 2 | 13:50-14:00 |
Gut Microbiota Dysbiosis After Androgen Deprivation Promotes Castration-Resistant Prostate Cancer Progression via TMAO-Mediated Remodeling of SPP1⁺ Tumor-Associated Macrophages |
|
|||||
| 3 | 14:10-14:20 |
Single-Cell Spatial Atlas Reveals Prostate Cancer Immune Microenvironment Heterogeneity and Identifies CCL18⁺ Macrophages as a Predictive Biomarker for Immunotherapy Response |
|
|||||
| 4 | 14:20-14:30 |
Wearable Low-Intensity Ultrasound Drives Fibroblasts Toward an FGF10⁺ Phenotype to Promote Postoperative Urethral Remodeling |
|
|||||
| 5 | 14:30-14:40 |
Exploring the Interrelationship Among Metabolic Syndrome, IGF-1, and Benign Prostatic Hyperplasia in a Sprague-Dawley Rat Model |
|
|||||
| 6 | 14:40-14:50 |
Environmental Endocrine-Disrupting Chemical Exposure Promotes Prostate Cancer Progression by Regulating the Tumor Immune Microenvironment |
|
|||||
| 7 | 14:50-15:00 |
Integrated CosMx Spatial Transcriptomics and FFPE Single-Nucleus RNA Sequencing Reveal Perineural Invasion-Associated Tumor Subpopulations and Castration-Resistant Features in Prostate Cancer |
|
|||||
| 8 | 15:00-15:10 |
Break |
||||||
| 1 | 15:10-15:20 |
Exercise Alleviates Benign Prostatic Hyperplasia via Synergistic Serotonylation and Lactylation |
|
|||||
| 2 | 15:20-15:30 |
Cytoplasmic Translocation of SIRT5 Remodels Glycolytic Metabolic Flux to Promote Castration-Resistant Prostate Cancer: Mechanisms and Therapeutic Strategies |
|
|||||
| 3 | 15:30-15:40 |
Multi-Omics Integration Reveals ZDHHC24 Drives Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Regulating Lipid Metabolism |
|
|||||
| 4 | 15:40-15:50 |
YWHAG Promotes Bladder Cancer Progression by Competitively Inhibiting FBXL7-Mediated Ubiquitination of BCLAF1 |
|
|||||
| 5 | 15:50-16:00 |
HE Slide-Based Spatial Gene Expression Prediction Model Deciphers Spatial Transcriptomic Features and Clinical Significance in Bladder Cancer |
|
|||||
| 6 | 16:00-16:10 |
Lactylation Atlas of Clear Cell Renal Cell Carcinoma Reveals Ferritin Lactylation Regulates Ferroptosis by Inhibiting Ubiquitin-Proteasome Degradation |
|
|||||
| 7 | 16:10-16:20 |
Single-Cell Sequencing Reveals SERPINE1⁺ Tumor Cells Remodel a Treg-Enriched Microenvironment via the JAK2/STAT3/TGF-β Axis to Drive Neoadjuvant Immunotherapy Resistance in Renal Cell Carcinoma |
|
|||||
| 1 | 16:40-16:50 |
UBTF Remodels the Androgen Receptor Chromatin Binding Landscape and Activates DNA Damage Repair Programs to Promote Prostate Cancer Progression |
|
|||||
| 2 | 16:50-17:00 |
GATAD1 Downregulation in Adrenal DLPC Promotes Ectopic Calcification of Arteries and Renal Interstitium |
|
|||||
| 3 | 17:00-17:10 |
YTHDF3 Facilitates Cytoskeletal Remodeling to Promote Mitochondrial Transfer and CD8⁺ T Cell Exhaustion in Prostate Cancer |
|
|||||
| 4 | 17:10-17:20 |
Mechanotransduction-Translation Coupling Mediates Cavernous Fibroblast Phenotypic Switching: A New Perspective on Diabetic Erectile Dysfunction Pathogenesis |
|
|||||
| 5 | 17:20-17:30 |
Application Value of ADAM19 in CTC EMT Subtyping and Prognostic Assessment for Renal Cell Carcinoma |
|
|||||
| 6 | 17:30-17:40 |
Targeting AREG⁺ Dendritic Cells Alleviates Renal Fibrosis Induced by Ischemia-Reperfusion Injury |
|
|||||
| 7 | 17:40-17:50 |
Therapeutic Effect and Preliminary Mechanisms of FAST Whole-Cell Tumor Vaccine Combined with SBRT in Renal Cell Carcinoma |
|
|||||
| 8 | 17:50-18:00 |
Identification of CD276 Ligands and Receptors and Exploration of Their Biological Functions in Urological Tumors |
|
|||||
| 1 | 18:00-18:10 |
Summary |
|
|||||